Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: Preoperative ultrasound in clinically node-negative melanoma

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1100-1106

  Chai, Christy Y ^a   Zager, Jonathan S ^b,c   Szabunio, Margaret M ^d   Marzban, Suroosh S ^b   Chau, Alec ^b   Rossi, Robert M ^b   Sondak, Vernon K ^b,c  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INGUINAL REGION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS RATE; NECK; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PREOPERATIVE CARE; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84862493409     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2172-7     Document Type: Article

References (44)

1. Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol. 1996;34:798-803. (Pubitemid 26137206)
2. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681-8. (Pubitemid 40486901)
3. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update, part II. J Am Acad Dermatol. 2010;62:737-48.
4. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update, part I. J Am Acad Dermatol. 2010;62:723-34.
5. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.
6. Van Akkooi AC, de Wilt JH, Verhoef C, et al. High positive sentinel node identification rate by EORTC Melanoma Group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer. 2006;42:372-80. (Pubitemid 43132893)
7. Uren RF, Howman-Giles R, Thompson JF, et al. High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol. 1999;43:148-52. (Pubitemid 29260073)
8. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 2004;5:673-80. (Pubitemid 40267852)
9. Voit C, Mayer T, Proebstle TM, et al. Ultrasound-guided fineneedle aspiration cytology in the early detection of melanoma metastases. Cancer. 2000;90:186-93. (Pubitemid 30438952)
10. Blum A, Schlagenhauff B, Stroebel W, et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer. 2000;88:2534-9. (Pubitemid 30331960)
11. Voit C, Mayer T, Kron M, et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer. 2001;91:2409-16. (Pubitemid 32552829)
12. Rossi CR, Seno A, Vecchiato A, et al. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur J Cancer. 1997;33:200-3.
13. Starritt EC, Uren RF, Scolyer RA, et al. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol. 2005;12:18-23. (Pubitemid 40486636)
14. Testori A, Lazzaro G, Baldini F, et al. The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients. Melanoma Res. 2005;15:191-8. (Pubitemid 40839467)
15. van Rijk MC, Teertstra HJ, Peterse JL, et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol. 2006;13:1511-6. (Pubitemid 44749663)
16. Voit C, Kron M, Schafer G, et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol. 2006;13:1682-9. (Pubitemid 44951477)
17. Voit CA, van Akkooi AC, Schafer-Hesterberg G, et al. Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol. 2009;27:4994-5000.
18. Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol. 2003;83:80-4. (Pubitemid 36667415)
19. Schmid-Wendtner MH, Paerschke G, Baumert J, et al. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res. 2003;13:183-8. (Pubitemid 36583982)
20. Voit C, Van Akkooi AC, Schafer-Hesterberg G, et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol. 2010;28:847-52.
21. Puleo CA, Messina JL, Riker AI, et al. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control. 2005;12:230-5. (Pubitemid 41552314)
22. Phan GQ, Messina JL, Sondak VK, Zager JS. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control. 2009;16:234-9.
23. Leong SP, Kim J, Ross M, et al. A phase 2 study of (99 m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961-9.
24. Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10:676-80. (Pubitemid 40486900)
25. Schafer-Hesterberg G, Voit C. Ultrasound pre sentinel node dissection. Melanoma Res. 2008;18:68-9. (Pubitemid 351628059)
26. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17. (Pubitemid 44465459)
27. van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up. Ann Surg Oncol. 2010;17:660-2.
28. 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol. 2010;17:2773-8.
29. Whitman GJ, Strom EA. Workup and staging of locally advanced breast cancer. Semin Radiat Oncol. 2009;19:211-21.
30. Sarvanan K, Bapuraj JR, Sharma SC, et al. Computed tomography and ultrasonographic evaluation of metastatic cervical lymph nodes with surgicoclinicopathologic correlation. J Laryngol Otol. 2002;116:194-9. (Pubitemid 34214429)
31. Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol. 2007;33:911-3. (Pubitemid 47279044)
32. Lam TK, Uren RF, Scolyer RA, et al. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res. 2009;19:94-9.
33. van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr Opin Oncol. 2010;22:169-77.
34. Thompson JF, Stretch JR, Uren RF, et al. Sentinel node biopsy for melanoma: where have we been and where are we going? Ann Surg Oncol. 2004;11:147S-151S.
35. Voit C, Van Akkooi AC, Schafer-Hesterberg G, et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol. 2010; 28:847-52.
36. van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578-85. (Pubitemid 44542045)
37. van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248:949-55.
38. Hocevar M, Bracko M, Pogacnik A, et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res. 2004;14:533-6. (Pubitemid 40221146)
39. Sibon C, Chagnon S, Tchakerian A, et al. The contribution of high-resolution ultrasonography in preoperatively detecting sentinel-node metastases in melanoma patients. Melanoma Res. 2007;17:233-7. (Pubitemid 47067081)
40. Sanki A, Uren RF, Moncrieff M, et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol. 2009;27:5614-9.
41. Thompson JF, Haydu LE, Uren RF, et al. Preoperative ultrasound assessment of sentinel nodes in melanoma patients does not provide reliable staging: results from a large multicenter trial. Ann Surg Oncol. 2011;18: S21, 46.
42. Lee MC, Eatrides J, Chau A, et al. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol. 2011;18:72-7.
43. Reynolds HM, Dunbar PR, Uren RF, et al. Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. Lancet Oncol. 2007;8:806-12. (Pubitemid 47308658)
44. Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 1999;189:195-204. (Pubitemid 29364693)